Elekta (OTCMKTS:EKTAY) Shares Gap Down – What’s Next?

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $5.39, but opened at $5.1150. Elekta shares last traded at $5.1150, with a volume of 753 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

Elekta Stock Down 1.9%

The firm has a market capitalization of $1.89 billion, a P/E ratio of -42.62 and a beta of 1.05. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87. The stock has a 50 day moving average of $5.27 and a 200-day moving average of $5.66.

Elekta (OTCMKTS:EKTAY) last posted its earnings results on Thursday, August 27th. The company reported $0.07 earnings per share for the quarter. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.31%. The firm had revenue of $372.30 million during the quarter. Research analysts predict that Elekta AB will post 0.43 earnings per share for the current fiscal year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.